Travere Therapeutics
The Executive Director, Strategic Accounts leads Travere’s U.S. Strategic Account Management organization, advancing national account strategy and institutional partnerships across academic medical centers, integrated delivery networks, and large nephrology practices. This role oversees the national SAM team, aligns cross-functional resources, and drives commercial growth to improve care for patients with rare diseases. The position may be filled at the Senior Director or Executive Director level based on experience and impact.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
22% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
National Account Director (NAD), Strategic IDNs & Integrated Health Systems
Invivyd
Executive Director, US Marketing, Rare Nephrology
AstraZeneca
Strategic Health Systems Manager, Eastern U.S.
Leica Biosystems
Director, Strategic Accounts, California (Remote)
Cengage Group
Medical Strategic Account Associate Director (NJ, NYC)
Sanofi
Account Director, Health Systems, Rare Disease
Ipsen